SART3 and squamous cell carcinoma: Also of potential therapeutic value is the massive elevation of Squamous cell carcinoma antigen recognized by T-cells 3 (SART3) which has been used to potentiate T cell responses in vaccination trials in cancer patients (+11.1-fold)55.